Figure 4From: Exogenous glucagon-like peptide-1 attenuates the glycaemic response to postpyloric nutrient infusion in critically ill patients with type-2 diabetesSerum C-peptide. When compared to placebo glucagon-like peptide-1 (GLP-1) caused no effect on C-peptide concentrations.Back to article page